Introduction
High blood pressure is the most important risk factor for cardiovascular disease, that is, stroke, ischaemic heart disease and heart failure. In a recent World Health Organization report, blood pressure was responsible for approximately half of all cardiovascular disease worldwide. 1 A more recent paper in the Lancet demonstrates that nonpersonal health interventions, such as legislation to lower the salt content of processed foods or mass-media messages to change diet, to lower systolic blood pressure and cholesterol are cost-effective ways to limit cardiovascular disease and could avert over 21 million DALYs (disability-adjusted life years) per year worldwide. 2 A recently published meta-analysis of one million adults in 61 prospective studies demonstrates that the relation between blood pressure and cardiovascular risk is considerably stronger than previously estimated and for the first time clearly quantifies the risk for systolic blood pressure. 3 In England the 1998 Health Survey found that in adults (16 years or older) 42% of men and 33% of women have high blood pressure, defined as systolic blood pressure X140 mmHg or diastolic (DBP) X90 mmHg or on blood pressure treatment. 4 With the information on systolic blood pressure from the meta-analysis of prospective studies, 3 we calculated the reductions in stroke and ischaemic heart disease that would occur if all individuals with high blood pressure in the UK had their systolic blood pressure reduced to 140 mmHgFthe now universally agreed target for blood pressure treatment.
Methods
Using the average systolic blood pressure for hypertensive individuals in the 1998 Health Survey for England and assuming that the average blood pressure of hypertensives in England is the same as in Scotland, Wales and Northern Ireland, we calculated the falls in systolic blood pressure if all hypertensive individuals had their systolic controlled (i. e. reduced to 140 mmHg). With these falls in systolic blood pressure, the percentage reductions in stroke and ischaemic heart disease were calculated using the hazard ratios of stroke or ischaemic heart disease for a given difference in systolic blood pressure in the new meta-analysis of prospective studies. 3 The reduction in the absolute number of stroke or ischaemic heart disease death is the product of the percentage reduction and the total number of stroke or ischaemic heart disease deaths.
Results
In hypertensive individuals, the Health Survey for England showed a progressive increase in systolic blood pressure with age 4 (Table 1) . For instance, in those aged 16-44 years the average systolic blood pressure was 146 mmHg, whereas for those aged X75 years, the average systolic blood pressure was 160 mmHg. If systolic blood pressure were controlled to 140 mmHg, there would be progressive falls in systolic blood pressure with increasing age, which would cause a reduction in stroke from 28 to 44% and ischaemic heart disease from 20 to 35% depending on age (Table 1) .
In the UK, there are approximately 60 700 stroke deaths and 124 000 ischaemic heart disease deaths each year.
5 Table 1 shows the numbers of stroke and ischaemic heart disease deaths in different age groups and the reductions in the number of stroke and ischaemic heart disease, which would occur with the falls in systolic blood pressure. Controlling all hypertensive individuals to a systolic blood pressure of 140 mmHg would prevent approximately 21 400 stroke deaths and 41 400 ischaemic heart disease deaths each year in the UK. Around half of those who suffer a stroke or ischaemic heart disease survive, there would be a proportionate decrease in these people as well. These amount to approximately 42 800 strokes and 82 800 ischaemic heart diseases saved, making a total of 125 600 events saved a year in the UK alone (total population around 60 million).
Discussion
Our analysis demonstrates that in the UK around a third of stroke and a third of ischaemic heart disease could be prevented if all hypertensive individuals had their systolic blood pressure controlled, that is, reduced to 140 mmHg. The blood pressure levels and control of blood pressure in many countries are similar to those in the UK, so the reductions in stroke and ischaemic heart disease worldwide, if the same control of high blood pressure could be obtained, would be immense.
Many of the previous treatment trials were based on diastolic blood pressure entry criteria and showed, in comparison to previous meta-analysis of prospective studies, 6 that for diastolic blood pressure the reductions in stroke in the treatment trials were approximately that predicted from the prospective studies. Whereas, for ischaemic heart disease, the reductions were approximately half that predicted. However, more recent studies of isolated systolic hypertension in the elderly have shown that the benefit found in the treatment trials for systolic blood pressure 7, 8 approximated to those predicted from the new meta-analysis of prospective studies. 3 Furthermore, it is likely that if blood pressure were controlled at an earlier age and for a longer period of time, the benefits would be greater than that seen in the 2-5 year average of most of the treatment trials.
The risk of cardiovascular disease increases with blood pressure throughout its range. A small reduction of a few mmHg in population systolic blood pressure will also be of major additional benefit in preventing stroke and ischaemic heart disease. This could be achieved by adopting a healthier lifestyle, for example, reducing salt intake and increasing consumption of fruit and vegetables, both obtainable objectives if the food industry cooperated.
The risks of high blood pressure and the benefits of treatment have been under-estimated. Currently, in the UK blood pressure is not well controlledFunder 10% reach the target systolic blood pressure level of 140 mmHg. 4 Therefore, very large numbers of stroke and ischaemic heart disease are occurring unnecessarily. Recent studies have shown that the target systolic blood pressure of 140 mmHg can be achieved 9,10 if a protocol is followed and individuals are treated with rational combinations of two to three drugs. 11 Furthermore, very little is 
